Basement membranes provide structural support and convey regulatory signals to cells in diverse tissues. Assembly of collagen IV into a sheet-like network is a fundamental mechanism during the formation of basement membranes. Peroxidasin (PXDN) was recently described to catalyze crosslinking of collagen IV through the formation of sulfilimine bonds.
INTRODUCTION
Once considered ubiquitously toxic, reactive oxygen species (ROS) are now recognized as important effector and signaling molecules in living organisms. Among diverse forms of reactive oxygen, hydrogen peroxide (H 2 O 2 ) seems to be a particularly important molecule (1).
H 2 O 2 has direct regulatory effects on signaling networks through reversible cysteine oxidation, but the best understood effects of H 2 O 2 are mediated by animal heme peroxidases (2) .
The family of mammalian heme peroxidases consists of myeloperoxidase (MPO), eosinophil peroxidase (EPX), thyroid peroxidase (TPO), lactoperoxidase (LPO) and peroxidasin (PXDN). A peroxidasin-like protein (PXDNL) was recently identified in humans (3) , however this protein lacks measurable peroxidase activity. Animal heme peroxidases (MPO, EPX and LPO) serve in the first line of host defense, while TPO has a crucial role in thyroid hormone synthesis. The idea that heme peroxidases participate in the formation of the extracellular matrix (ECM) of animals first gained support from experiments on sea urchin eggs, where stabilization of the fertilization envelope is partially mediated by ovoperoxidasecatalyzed crosslinking of tyrosine residues (4) . ECM modification through dityrosine formation was also described to have a role in cuticle formation of C. elegans (5) .
Compared to other members of the enzyme family peroxidasin is quite unique since besides its peroxidase domain it contains modules that are characteristic of constituents of the ECM (6;7). These domains include N-terminal leucine-rich repeats, immunoglobulin C2 domains and a vWF C-type domain at the very C-terminus of the protein. The unique combination of peroxidase domain along with ECM motifs suggests a special role for PXDN in ECM formation.
PXDN was first described in Drosophila and subsequent studies revealed that it is ubiquitously expressed across the animal kingdom (6;8-10) . Although secretion of PXDN into the extracellular space was demonstrated in both Drosophila and primary mammalian cells, the physiological significance of its peroxidase activity was unknown for a long time.
Recently Bhave et al. identified PXDN as the long-sought player in collagen IV biosynthesis that catalyzes crosslinking of collagen IV trimers through their NC1 domains (11) . Coupling of the NC1 domains occurs through sulfilimine bonds that were only recently recognized in living organisms (12) . While vast amount of data have been collected about the structure and enzymatic activity of other members of the animal heme peroxidase family (13), we know very little about the PXDN protein and the mechanism of collagen IV crosslinking. In this study we sought to determine the supramolecular architecture of PXDN and the structural determinants of its peroxidase activity and adhesive properties. In rescue experiments using embryonic fibroblasts prepared from PXDN-deficient animals we also determined the structural requirements of PXDN for collagen IV crosslinking.
MATERIALS AND METHODS

Generation of recombinant PXDN constructs
cDNA encoding full-length human PXDN was directly inserted into pcDNA3.1/V5-His-TOPO vector using TOPO TA Expression Kit (Invitrogen, Life Technologies). Targeted mutations were introduced into the full-length sequence with double-primer PCR method using complementary mutagenic oligonucleotide pairs (Sigma-Aldrich). Mutated constructs were amplified with Phusion Hot Start II High-Fidelity DNA Polymerase (Thermo Scientific).
To avoid the occurrence of any undesired mutations, DNA regions containing the targeted nucleotide changes were sequenced (Eurofins MWG Operon) and cloned into the original vector backbone using suitable restriction endonuclease pairs (Fermentas, Thermo Scientific).
Truncated constructs were generated by inserting particular regions of PXDN coding sequence into pcDNA3.1/V5-His-TOPO vector using TA cloning strategy. We obtained cDNA of a previously described shorter PXDN isoform (14) by 5' and 3' RACE using poly(A) RNA of cadmium chloride-stimulated EB1 colon carcinoma cell line and used it to generate the N-termially truncated PXDN 695-1479 construct. To create PXDN 1-26+696-1479 , oligonucleotides corresponding to the original secretory signal sequence (aa1-26) of PXDN were hybridized and then ligated between unique restriction sites following the start codon of PXDN 695-1479. Insert of the C-terminally truncated PXDN 1-1412 construct was amplified with Phusion Hot Start II from the full-length PXDN sequence with specific PCR primers flanking the selected nucleotide region. Appropriate restriction fragments of PXDN 1-26+696-1479 and PXDN were joined with T4 DNA Ligase (Thermo Scientific), thus forming PXDN 1-26+696-1412. All coding regions synthesized in polymerase chain reactions were sequenced to rule out any infidelity between the template DNA and the PCR product. Following the removal of the head and red tissues, remaining body wall of the embryos was finely minced and repeatedly incubated with 5 ml 1x Trypsin/Versene (EDTA) (Lonza) at 37 o C for 10 minutes. After sedimentation of undigested tissues, supernatant was mixed with 40 ml freshly prepared medium consisting of DMEM, 10% FBS, 100 U/ml penicillin/100 μg/ml streptomycin, 1x MEM Non-Essential Amino Acid Solution (NEAA; Sigma-Aldrich), 1x
MEM Vitamin Solution (Sigma-Aldrich) and 50 μg/ml ascorbic acid (Sigma-Aldrich). The cells were centrifuged at 377 x g for 5 minutes, then the pellet was resuspended in fresh medium and was plated in sterile flasks. After their first passage MEFs were grown to 90% confluency when they were frozen in numerous vials for long-term storage. We used thawed P1 MEF colonies for experiments requiring this cell type. Transfection of PXDN mutant
MEFs was carried out with electroporation (1 pulse, 1350 V, 30 ms) using Neon Transfection System (Invitrogen). Cell cultures were maintained in a 37 o C incubator with humidified atmosphere of 5% CO 2 in air.
Primary antibodies
Polyclonal antibodies recognizing the C-terminal segment of human (α-hsPXDN, aa1329-1479) or mouse (α-mmPXDN, aa1326-1475) PXDN were raised in rabbits following repeated intracutaneous injections of GST-tagged peptides. Sera of the immunized animals were depleted of GST-specific antibodies and then were affinity-purified with Affigel 10 (Bio-Rad) coupled to PXDN peptides which were previously used for the immunization. Specificity of α-mmPXDN was tested with knockout control in all the described applications while validation of α-hsPXDN has already been reported in our previous paper (9 domain of collagen IV alpha 2 isoform (α-coll4a2) was acquired from Chondrex, Inc..
Analysis of PXDN oligmerization
HUVECs and HEK293 freestyle cells expressing recombinant PXDN constructs were preincubated with 300 mM HEPES pH 7.4 containing 1 mM N-ethylmaleimide (NEM;
Sigma-Aldrich) for 10 minutes, and then were lysed in RIPA buffer (0. Expression of recombinant proteins was checked and compared in Western blots 24 hours after transfection, collagenase digestion of corresponding samples was started 3 days later to provide enough time for secretion and assembly of collagen IV network.
Detection of NC1 crosslinking
Analysis of PXDN secretion
Cos7 cells were seeded in 12-well cell culture plates and were transfected with several recombinant PXDN constructs right after attachment. 12 hours after transfection the DMEM- 
Western blotting and immunoprecipitation
Following gel electrophoresis of reduced or non-reduced samples, separated proteins were blotted on nitrocellulose membranes. Blots were blocked in PBS containing 0.1% Tween Triton X-100, 1 mM PMSF, 140 mM NaCl and 30 mM Tris pH 7.4), purified proteins were eluted with non-reducing Laemmli buffer and then were run on 4% polyacrylamide-SDS gels.
Stained protein bands were cut out and were submitted to mass spectrometric examination.
Mass spectrometric analysis
Excised protein bands of HUVEC or V5-positive precipitates were in gel digested with side- 
Alignment of human heme peroxidase sequences
Multiple sequence alignment of human myeloperoxidase (UniProt accession number: P05164), eosinophil peroxidase (UP Acc#: P11678), lactoperoxidase (UP Acc#: P22079), thyroid peroxidase (UP Acc#: P07202) and peroxidasin (UP Acc#: Q92626) was carried out using web format of Clustal-Omega program (15) .
Statistical analysis
Western 
RESULTS
Collagen IV crosslinking is absent in PXDN-deficient mouse embryonic fibroblasts
Collagen IV was recently identified as a substrate of PXDN (11) . In a reaction thought to be universal in the animal kingdom the enzyme crosslinks the NC1 domains of collagen IV protomers through the formation of sulfilimine linkages. First we wanted to examine whether crosslinking collagen IV molecules is a physiological function of the endogenously expressed mammalian PXDN. To achieve this goal we prepared mouse embryonic fibroblasts (MEFs) from PXDN-deficient animals which were created by the zinc-finger endonuclease technique.
To confirm the knockout phenotype we studied the presence of the PXDN protein in lysates of wild-type and PXDN knockout cells. Figure 1A (left panel) shows that PXDN was absent in MEFs prepared from PXDN mutant animals. We digested wild-type and knockout MEF lysates with collagenase and analyzed the ratio between NC1 dimers and monomers by Western blot. While digests of wild-type MEFs contained both dimers and monomers, crosslinked NC1 domains were totally absent in knockout lysates ( Figure 1B) . These experiments proved the essential role of mammalian PXDN in collagen IV crosslinking.
Trimerization of heterologously-and endogenously expressed mammalian PXDN
In our previous study we demonstrated the widespread expression of the pxdn gene and the presence of the protein in different types of human primary cells including pulmonary, dermal fibroblasts and HUVECs (9) . To get a better understanding of the function of this complex protein first we decided to study the supramolecular organization of PXDN which was previously found to oligomerize into trimers in Drosophila (6). When PXDN was detected in non-reduced samples of HUVECs, three bands were recognized at approximately 160, 300
and over 500 kD, respectively (Figure 2A, left panel) . Importantly, the band with the highest molecular mass was the most abundant detected, suggesting that PXDN could form oligomers or interact with other unknown proteins. We created a HEK293-based cell line that stably expressed high amount of a V5 epitope-tagged version of PXDN. When lysates from this cell line were analyzed under non-reducing conditions, the same pattern of PXDN positive bands was observed (Figure 2A, left panel) . In accordance with previous reports (8;9), in reduced samples PXDN was detected at the expected size of 165 kD (Figure 2A, right panel) . We purified the V5 epitope-tagged PXDN protein from transfected HEK293 cells by immuneaffinity chromatography. After Coomassie blue staining of the separated proteins we detected three bands at the molecular masses already described above ( Figure 2B ). Mass spectrometric analysis revealed that the bands contained only PXDN (Supplementary figure 2) . In other experiments we used PXDN-specific antibody and immunoprecipitated the protein from HUVEC lysates and analyzed the isolated proteins by mass spectrometry. These experiments confirmed that the band at the 500 kD marker contained only peroxidasin (Supplementary   figure 3) . Altogether, the above described experiments suggest that mammalian PXDN forms oligomers and based on its electrophoretic mobility, the dominant form appears to be trimeric.
Disulphide bond formation between conserved cysteines mediates the oligomerization of PXDN
In subsequent experiments we investigated the mechanism of PXDN oligomerization.
Dimerization of LPO was previously described to be dependent on the enzymatic activity of the protein (16), therefore we examined if the peroxidase activity of PXDN is required for the assembly of PXDN trimers. We mutated two highly-conserved amino acids which are located in the active site of the enzyme and were previously proved to be essential for enzymatic activity (13) . As shown in Figure 3A , the Q823W, D826E mutations erased the peroxidase activity of PXDN while oligomerization of the protein remained unaffected ( Figure 3B ).
Dimerization through cysteine residues has been described for other members of the peroxidase family, including MPO (13) . We aimed to locate the positions of cysteines that mediate coupling of PXDN monomers. To achieve this, first we expressed Disappearance of the highest molecular mass form of PXDN was only observed when C1315
was mutated ( Figure 4B) . We also tested different combinations of the C-terminal mutations and these experiments confirmed the importance of C1315 in the oligomerization process ( Figure 4B) . When all three cysteines were mutated (C1315S, C1316S, C1319S), only the monomeric form was observed. Interestingly, in the case of the C1315S and C1319S mutants we observed additional bands above the expected molecular mass of the oligomeric forms. It is possible that disufide formation between a hitherto unknown chaperone and PXDN is responsible for the appearance of these bands which were not analyzed further. Our next target, the C736 residue is also conserved among PXDNs of different species examined (data not shown). Figure 4C shows that the C736S mutant did not form the high molecular mass oligomer and only dimeric and monomeric forms were detected. Importantly, simultaneous mutations of C736 and C1315 resulted in the exclusive formation of PXDN monomers, thus proving the key role of C736 and C1315 in the oligomerization process ( Figure 4C ).
Trimerization of PXDN is essential for optimal collagen IV crosslinking
PXDN is a secreted peroxidase with adhesive properties so we decided to test the structural basis for each of its previously described features. To investigate the structural requirements for secretion we analyzed the cell culture medium of transfected Cos7 cells for its PXDN content by Western blot. To exclude the possibility that the PXDN signal origins from unattached cells, we also tested the medium for actin. As shown in Figure 5 , the presence of the secretory signal (between amino acids 1 and 26) was necessary and sufficient to transport the wild-type protein as well as different mutant PXDN forms to the extracellular space.
Next we examined whether the enzymatic activity of PXDN is dependent on its oligomeric structure and presence of protein modules that lay outside of the peroxidase domain. When tested in Amplex Red Peroxidase Assay, the C736S, C1315S double mutant and the protein lacking the C-terminal vWF domain were equally active as the wild-type enzyme. On the other hand, the concurrent absence of N-terminal leucine-rich repeats and IgG-like domains erased the catalytic activity of PXDN ( Figure 6A) . Results of the previously described experiments on KO MEFs suggested that these cells offer a promising tool for studying the crosslinking activity of different PXDN mutants in rescue experiments.
We expressed wild-type PXDN and different mutant forms of the protein in knockout MEFs ( Figure 6B ) and studied the formation of NC1 dimers by Western blot analysis. As expected, wild-type PXDN efficiently catalyzed the formation of NC1 dimers, whereas the loss of function Q823W, D826E mutant did not support the formation of crosslinks ( Figure 6C) . The PXDN construct lacking the C-terminal vWF C-type domain (PXDN ) was equally active as the wild-type protein, but the monomeric C736S, C1315S form was less effective, although it retained its ability to support the crosslinking reaction ( Figure 6C ). Since the wild-type protein and the monomeric mutant were equally active in the Amplex Red assay, we were interested in finding the explanation for their different activity in collagen crosslinking experiments.
When we immunostained PXDN in Cos7 cells that heterologously expressed the protein we observed a prominent localization within the endoplasmic reticulum (ER) ( Figure   7 ) as described in our earlier paper (9) . Besides the ER localization (Figure 7A-D) we also observed punctuate structures that were strongly positive for PXDN ( Figure 7A, B, D) . When we stained unpermeabilized cells, PXDN was detected only at these structures indicating their localization on the surface of the cells. The absence of the peroxidase activity or the lack of the C-terminal vWF C-type domain did not alter punctuate staining pattern of PXDN ( Figure   7E, F, I ), however, the monomeric form failed to appear on the surface of the cells ( Figure   7G, H) . In subsequent experiments we compared the localization of the wild-type protein with that of the monomeric C736S, C1315S mutant in PXDN-deficient MEFs. The wild-type protein again was observed in the punctuate pattern, which was also detectable at the plasma membrane of unpermeabilized cells (Figure 8A, C) . The monomeric form, however, was accessible to the antibody only after permeabilization of the cells (Figure 8B, D, E) . domains, a coupling mechanism which has been identified only in collagen IV so far (12) .
The animal heme peroxidase PXDN has been shown to catalyze the formation of sulfilimine links in a reaction, where the enzyme produces hypohalous acids as intermediates for the oxidation of a highly conserved Met residue in the NC1 domain (11) . Although peroxidase inhibitors were previously shown to inhibit collagen IV crosslinking in a murine embryonic carcinoma cell line (11), evidence for PXDN-mediated coupling of NC1 domains being a physiological pathway of ECM formation in mammals has been lacking so far. In our experiments we compared the formation of NC1 dimers between wild-type and PXDNdeficient MEFs and found that KO cells failed to form crosslinked NC1 domains. These experiments also indicated that compensatory pathways for sulfilimine-mediated collagen IV coupling unlikely exist in mammals, highlighting the physiological significance of the PXDNcatalyzed reaction. We did not observe any difference between the collagen IV content of wild-type and PXDN KO MEFs (data not shown), suggesting that the absence of sulfinimine links does not lead to a compensatory increase of collagen IV synthesis.
Several molecular details are known about the organization of basement membranes, including the molecular architecture and interactions of proteins that orchestrate the assembly process (19) . On the other hand, no structure-function analysis on PXDN has so far been reported and little is known about the supramolecular organization of the protein. Drosophila PXDN was originally described to form trimers, but the mechanism of oligomerization was not pursued further by the authors (6). Our experiments on both endogenously-and heterologously-expressed PXDN revealed that the mammalian protein also exists in a trimeric form. PXDN is unique hybrid protein composed of domains that are characteristic of constituents of the ECM and a peroxidase domain that is highly homologous to other members of the animal heme peroxidase family (7) . Interestingly, multimerization is a shared feature of both heme peroxidases and non-enzymatic BM proteins including laminin and collagen IV itself. LPO, for example, was described to form dimers held together by dityrosine links, the formation of which is dependent on the peroxidase activity of the enzyme (16) . A distinct heme peroxidase, MPO also exists in dimers, however its structure is stabilized by intermolecular disulphide bridges (13) . For PXDN we found the peroxidase activity dispensable for supramolecular assembly and intermolecular disulfide bridge formation was identified as the key mechanism of oligomerization. Creating a series of truncation and point mutants enabled us to identify two cysteines (C736 and C1315) that are responsible for the assembly of the mammalian PXDN trimer. When these cysteines were mutated simultaneously, only monomeric PXDN was detected. Multiple sequence alignment of PXDN sequences from different species revealed that these cysteines are highly conserved across the animal kingdom, suggesting a universal mechanism for PXDN oligomerization.
Furthermore, we recently identified a novel homolog of PXDN, PXDNL (3), which also contains these cysteines at identical positions. Sequence similarity between the homologs might be indicative for PXDNL oligomerization as well. There are two additional cysteines (C1316 and C1319) in the proximity of C1315. Point mutations of these residues, either alone or in combination, did not interfere with the oligomerization process. When C1315 was mutated into serine, while C1316 and/or C1319 were left intact, we observed dimers as dominant forms of PXDN. We propose that in the absence of C1315 the remaining cysteines can still form "forced" intermolecular disulfide bridges, resulting the assembly of dimers.
This explanation is supported by the observation that the triple mutant (C1315S, C1316S, C1319S) form of PXDN is exclusively monomeric.
Close to its C-terminus, the Drosophila PXDN contains an amphipatic -helical region, which was proposed to form homotrimeric coiled coil (6) . A homologous region between amino acids 1383 and 1411 is also recognizable in the mammalian protein and we assume that trimerization via this region positions the C736 and C1315 residues to form intermolecular disulfide bonds leading to the assembly of a stabilized PXDN trimer.
When tested in Amplex Red Peroxidase Assay, we found that the monomeric (C736S, domains erased the peroxidase activity of PXDN. We assume that this latter modification interferes with folding of the peroxidase domain by an unknown mechanism, which was not pursued further in this study. To investigate the biological activity of the different PXDN mutants in a more physiological setting, we reintroduced them into PXDN-deficient MEFs and examined whether they were able to rescue the collagen IV crosslinking defect of the knockout cells. Interestingly, when compared to the activity of the wild type protein, we found the monomeric (C736S, C1315S) form less effective in these experiments, suggesting that optimal coupling of NC1 domains requires trimerization of the protein. On the other hand, the lack of the vWF C-type domain did not affect the crosslinking activity of PXDN, which was absolutely dependent on the peroxidase activity of the protein.
When we studied the cellular localization of the different PXDN mutants we observed interesting differences, which might explain the previously discussed discrepancies in collagen IV crosslinking. All of the examined constructs showed the characteristic appearance in the endoplasmic reticulum, which was previously described by us for both endogenouslyand heterologously expressed PXDN (9) . Intriguingly, wild-type PXDN or mutants which were previously shown to retain their ability to form trimers, were also detected in separate, Multiple sequence alignment indicates that human heme peroxidases share 14 highly conserved cysteine residues that have previously been reported to form intramolecular disulphide bonds stabilizing tertiary structures of promyeloperoxidase and lactoperoxidase.
PXDN contains an additional cysteine at position 736 (in blue box) and other three residues in close proximity to the C-terminus of peroxidase domain at positions 1315, 1316, 1319 (in pink boxes) that are candidates to form interchain linkages during the assembly of PXDN oligomers.
